Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does prostate-cancer treatment place a strain on the heart?

Nature·2022
Same author

Metastatic prostate cancer: seeking a fresh chance of recovery.

Nature·2022
Same author

Out of your skin.

Nature biotechnology·2020
Same author

Researchers Find Discrepancies in Gene Panel Tests for Cancer.

Journal of the National Cancer Institute·2018
Same author

M. D. Anderson Breaks With IBM Watson, Raising Questions About Artificial Intelligence in Oncology.

Journal of the National Cancer Institute·2018
Same author

New Guidelines Allow Some Patients With Chronic Myeloid Leukemia To Go Off Treatment.

Journal of the National Cancer Institute·2018

Related Experiment Video

Updated: May 30, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

CA-125: a biomarker put to the test

Charlie Schmidt

    Journal of the National Cancer Institute
    |August 20, 2011
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics
    04:33

    CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics

    Published on: December 8, 2023

    Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
    11:00

    Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs

    Published on: June 12, 2018

    Related Experiment Videos

    Last Updated: May 30, 2026

    A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
    10:12

    A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

    Published on: August 8, 2013

    CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics
    04:33

    CRISPR-Cas-mediated Multianalyte Synthetic Urine Biomarker Test for Portable Diagnostics

    Published on: December 8, 2023

    Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
    11:00

    Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs

    Published on: June 12, 2018